Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released May 5, 2022, after the close
10-Q filed May 5, 2022, 35 days after period end · 0000320017-22-000042
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Net Income | -$4.23M | -$8.06M | -$3.99M | -$4.37M |
| EPS Diluted | -$1.05 | -$0.19 | -$0.38 | -$0.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
